These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy. Azamfirei L; Copotoiu SM; Branzaniuc K; Szederjesi J; Copotoiu R; Berteanu C Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):402-4. PubMed ID: 16998949 [TBL] [Abstract][Full Text] [Related]
30. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028 [TBL] [Abstract][Full Text] [Related]
31. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720 [TBL] [Abstract][Full Text] [Related]
32. Linezolid contributed to Clostridium difficile colitis with fatal outcome. Zabel LT; Worm S Infection; 2005 Jun; 33(3):155-7. PubMed ID: 15940418 [TBL] [Abstract][Full Text] [Related]
33. Linezolid for the treatment of adults with bone and joint infections. Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ Int J Antimicrob Agents; 2007 Mar; 29(3):233-9. PubMed ID: 17204407 [TBL] [Abstract][Full Text] [Related]
34. Experience with linezolid therapy in children with osteoarticular infections. Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803 [TBL] [Abstract][Full Text] [Related]
35. Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Savard S; Desmeules S; Riopel J; Agharazii M Am J Kidney Dis; 2009 Dec; 54(6):e17-20. PubMed ID: 19733945 [TBL] [Abstract][Full Text] [Related]
36. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Lawrence KR; Adra M; Gillman PK Clin Infect Dis; 2006 Jun; 42(11):1578-83. PubMed ID: 16652315 [TBL] [Abstract][Full Text] [Related]
37. Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Narita M; Tsuji BT; Yu VL Pharmacotherapy; 2007 Aug; 27(8):1189-97. PubMed ID: 17655517 [TBL] [Abstract][Full Text] [Related]
38. Linezolid-induced bradycardia: a case report. Tartarone A; Gallucci G; Iodice G; Romano G; Coccaro M; Vigliotti ML; Mele G; Matera R; Di Renzo N Int J Antimicrob Agents; 2004 Apr; 23(4):412-3. PubMed ID: 15081095 [TBL] [Abstract][Full Text] [Related]
39. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Beekmann SE; Gilbert DN; Polgreen PM; Diagn Microbiol Infect Dis; 2008 Dec; 62(4):407-10. PubMed ID: 18929458 [TBL] [Abstract][Full Text] [Related]
40. Potential for linezolid-related blindness: a review of spontaneous adverse event reports. Brown J; Aitken SL; van Manen RP Pharmacotherapy; 2011 Jun; 31(6):585-90. PubMed ID: 21923442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]